SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION

Amiodarone is one of the basic antiarrhytmic drugs for atrial fibrillation treatment. However application of amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome can induce ventricular fibrillation. Amiodarone usage in these patients should be accompanied by readiness f...

Full description

Bibliographic Details
Main Authors:	D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	amiodarone atrial fibrillation wolff-parkinson-white syndrome ventricular fibrillation
Online Access:	https://www.rpcardio.online/jour/article/view/879

Similar Items

Atrial fibrillation with WolffParkinson-White syndrome: A case report
by: Abdulmecit Afsin, et al.
Published: (2017-12-01)

Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings
by: Jinzhu Hu, et al.
Published: (2019-07-01)

Atrial fibrillation and Wolff–Parkinson–White syndrome: A double blow for the cardiologist
by: George Bazoukis, et al.
Published: (2022-07-01)

Atrial Fibrillation in Wolff-Parkinson-White Syndrome
by: Andy Kieu, DO, et al.
Published: (2019-10-01)

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome
by: Shaobo Shi, MD, PhD, et al.
Published: (2017-01-01)

A rare manifestation of atrial fibrillation in the presence of Wolff-Parkinson-White syndrome: tachycardia-induced cardiomyopathy
by: Aleks Değirmencioğu, et al.
Published: (2014-02-01)

Amiodarone can still be a drug of choice at emergency departments for pre-excited atrial fibrillation even in the face of guidelines prohibition
by: Babak Payami, et al.
Published: (2023-05-01)

Asemptomatik Wolff-Parkinson-White paterni
by: Ali Karakuş, et al.
Published: (2016-12-01)

Predictors of time to conversion of new‐onset atrial fibrillation to sinus rhythm with amiodarone therapy
by: Ihsan Dursun, et al.
Published: (2020-08-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
by: Abolfath Alizadeh, et al.
Published: (2022-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
by: Hesham S. Taha, et al.
Published: (2022-05-01)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
by: Maciej T. Wybraniec, et al.
Published: (2023-06-01)

The History of the Wolff–Parkinson–White Syndrome
by: Melvin M. Scheinman
Published: (2012-07-01)

WOLFF PARKiNSON WHiTE SENDROMLU HASTANIN ANESTEZİ YÖNETİMİ: OLGU SUNUMU
by: Sedat Hakimoğlu, et al.
Published: (2015-03-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
by: Niloofar Dadashpour, et al.
Published: (2015-06-01)

Wolff-Parkinson-White Syndrome: A Case for High-Fidelity Simulation in Emergency Medicine
by: Michael Fitch, et al.
Published: (2008-04-01)

Sindrom Wolff Parkinson White
by: Sri Endah Rahayuningsih
Published: (2016-12-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
by: Nuri Köse, et al.
Published: (2022-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
by: Shuxin Hou, et al.
Published: (2016-01-01)

Pre-excited atrial fibrillation revealed at a very delayed age: case report
by: Thierno Hamidou Diallo, et al.
Published: (2023-05-01)

Tachyarrhythmia in Wolff-Parkinson-White Syndrome
by: Kelly Kesler, et al.
Published: (2016-06-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
by: O. V. Gaisenok
Published: (2016-01-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
by: Daisuke Horiuchi, MD, et al.
Published: (2014-06-01)

Prophylactic effect of Amiodarone and in combination with vitamin C in reducing atrial fibrillation after coronary artery bypass
by: Alireza Kamali, et al.
Published: (2021-09-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01)

Wolff–Parkinson–White syndrome and peripartum cardiomyopathy
by: Mehdi Ghaderian, et al.
Published: (2022-01-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
by: Mohamed Ali Ahmed, et al.
Published: (2022-09-01)

1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW
by: R. R. Mamatkazina, et al.
Published: (2015-12-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
by: Kuan-Cheng Lai, et al.
Published: (2018-05-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021-08-01)

Wolff-Parkinson-White en un EKG que cumple criterios de crecimiento ventricular derecho.
by: Carlos Quesada Aguilar
Published: (2014-07-01)

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
by: Li Y, et al.
Published: (2023-12-01)

Pharmacological Therapy for Fibrillations
by: Akira Fujiki, MD
Published: (2007-01-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
by: Melissa E. Middeldorp, et al.
Published: (2020-11-01)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
by: Irina Nordkin, et al.
Published: (2021-01-01)

Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution’s experience
by: Elizabeth M. Colwell, et al.
Published: (2018-06-01)

Síndrome de Wolff Parkinson White y embarazo
by: Leticia Luchinetti, et al.
Published: (2011-12-01)

Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita
by: S. N. Bel'diev
Published: (2016-03-01)

Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial
by: Mohammad Hassan Nemati, et al.
Published: (2016-06-01)